Noom CEO Geoff Cook Interview: Wall Street Journal GLP-1 Cost Ad

On The Pen With Dave Knapp

0:00

-27:58

Noom CEO Geoff Cook Interview: Wall Street Journal GLP-1 Cost Ad

In this powerful interview, Noom CEO Geoff Cook opens up about his mission to bring down the cost of GLP-1 medications like Ozempic, Wegovy, and Zepbound—and why he believes compounding pharmacies could play a critical role in making these life-changing d

On The Pen

Apr 09, 2025

WAYS TO SUPPORT MY WORK ⬇️

💊 OVER THE COUNTER ORAL PEPTIDE SUPPLIMENTS:
BPC-157 // Can’t Weight // TB4-FRAG // KPV
Sign up here and use code “OTP10” to save 10%
https://integrativepeptides.com/OTP

WHY I TRUST INTEGRATIVE PEPTIDES:
🇺🇸 Made in the USA
📋 CGMP Compliant (FDA oversight of their products)
🧑‍⚕️Trusted and Sold By Doctors and Clinics all over the USA

📕 GET MY BOOK!
Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
https://amzn.to/4gAXrz4

SOCIALS:
📸 : https://www.instagram.com/onthepen.official/profilecard/?igsh=dTRhY3JkYWo1bTIx
🇨🇳: https://www.tiktok.com/@manonthemounjaro?_t=ZP-8sr5PrUuPQl&_r=1
👾: https://discord.gg/ZHeUh7WV
📺: https://youtube.com/@ManOnTheMounjaro?feature=shared
❌: https://x.com/manonthepen?s=21
💻: https://www.onthepen.com

Noom CEO Geoff Cook Interview: Wall Street Journal GLP-1 Cost Ad

Discussion about this episode